Hosted on MSN
Eli Lilly nears $2B-plus deal for Kelonia to expand cancer pipeline: WSJ
Eli Lilly (LLY) is in advanced negotiations to acquire Kelonia Therapeutics in a transaction valued at more than $2 billion, The Wall Street Journal reported Sunday, citing people familiar with the ...
Hosted on MSN
Eli Lilly eyes Kelonia Therapeutics in $7B deal with $3.25B to be paid up front, and before investors could buy. How to get in early on market moves
This article adheres to strict editorial standards. Some or all links may be monetized. Eli Lilly (NYSE: LLY) has officially signed an agreement to acquire cancer biotech Kelonia Therapeutics in a ...
FierceBiotech
ASCO: Lilly exec points to ‘nutty’ 100% response rate for in vivo CAR-T as justifying Kelonia buyout
Kelonia Therapeutics has shared the largest slice of data yet for its in vivo CAR-T, helping to justify the $3.2 billion price tag that Eli Lilly recently paid to buy the Boston biotech. All 18 ...